Related Experiment Videos

DNA Damage Induces a Secretory Program in the Quiescent TME that Fosters Adverse Cancer Phenotypes

Luis Gomez-Sarosi1, Yu Sun2, Ilsa Coleman1

  • 1Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington.

Insights

Genotoxic stress in quiescent prostate fibroblasts triggers a secretory program that enhances cancer cell proliferation, invasion, and therapy resistance. Suppressing this program may improve treatment outcomes.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Tumor microenvironments (TME) comprise diverse cell types influencing cancer progression.
  • DNA damage can induce cellular phenotypes promoting tumor growth and treatment resistance.
  • Previous studies on genotoxic stress focused on actively proliferating cells, not quiescent cells dominant in TME.

Purpose of the Study:

  • To assess the transcriptional response to genotoxic damage in quiescent prostate fibroblasts.
  • To determine if quiescent cells induce a secretory damage response similar to proliferating cells.
  • To investigate the impact of this response on prostate cancer cell behavior and treatment resistance.

Main Methods:

  • Gene expression profiling of quiescent human prostate fibroblasts exposed to genotoxic agents.
  • In vivo assessment of transcriptional changes in quiescent prostate stroma.
  • Co-culture experiments to evaluate the paracrine effects on prostate cancer cells.

Main Results:

  • Quiescent fibroblasts exhibited a secretory damage response comparable to actively dividing cells.
  • Genotoxic stress significantly upregulated growth factors and cytokines (e.g., IL1β, MMP3, IL6, IL8) in quiescent cells.
  • Secreted factors from damaged quiescent cells promoted cancer cell proliferation, invasion, and chemoresistance.

Conclusions:

  • Benign quiescent cells in the TME activate a secretory program upon genotoxic stress.
  • This program contributes to cancer cell proliferation, invasion, and therapy resistance.
  • Targeting this secretory pathway presents a potential strategy to enhance cancer treatment efficacy.

Related Concept Videos